Formylpeptide receptor regulation in cardiopulmonary disease

Cardiopulmonary diseases, such as diabetic cardiomyopathy and pulmonary arterial hypertension, are major causes of death globally. Current treatments often fall short because they don’t address the root causes. This research shows that an unbalanced immune response plays a key role in these conditions. By adjusting this inflammation, it may be possible to reduce damage to the heart and lungs. The study also finds that proteins involved in communication between cells can affect how well treatments work. These insights could lead to new, more effective therapies for chronic heart and lung diseases by targeting the disease at its source.